# Blood Bank of Alaska, Inc. – FDA Inspection, Mar 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/blood-bank-of-alaska-inc/7348891e-443f-40cd-a708-18d4e6ef5656
Source feed: FDA_Inspections

> FDA inspection 1004501 of Blood Bank of Alaska, Inc., March 14, 2017. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1004501
- Company Name: Blood Bank of Alaska, Inc.
- Inspection Date: 2017-03-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1254661 - 2024-11-13
- FDA Inspection 1091669 - 2019-05-16
- FDA Inspection 915800 - 2015-02-27
- [FDA Inspection 820700 - 2013-03-04](https://www.keypedia.com/records/fda_inspections/blood-bank-of-alaska-inc/4753ce8f-b701-4f64-b8df-ba6c35d81f7a)
- FDA Inspection 729880 - 2011-05-04

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/peter-s-kessler/f3a9dea7-3a2d-4c86-9ec6-97791f9b6c21)

Company: https://www.keypedia.com/companies/blood-bank-of-alaska-inc/d7d1f084-fd0e-4d03-b472-61ba8d8f5b4a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d